Cargando…
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases
Diseases of the pulmonary alveolus, such as pulmonary fibrosis, are leading causes of morbidity and mortality, but exceedingly few drugs are developed for them. A major reason for this gap is that after inhalation, drugs are quickly whisked away from alveoli due to their high perfusion. To solve thi...
Autores principales: | Ferguson, Laura T., Ma, Xiaonan, Myerson, Jacob W., Wu, Jichuan, Glassman, Patrick M., Zamora, Marco E., Hood, Elizabeth D., Zaleski, Michael, Shen, Mengwen, Essien, Eno-Obong, Shuvaev, Vladimir V., Brenner, Jacob S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231510/ https://www.ncbi.nlm.nih.gov/pubmed/37266328 http://dx.doi.org/10.1002/anbr.202200106 |
Ejemplares similares
-
Targeting drug delivery in the vascular system: Focus on endothelium
por: Glassman, Patrick M., et al.
Publicado: (2020) -
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
por: Omo-Lamai, Serena, et al.
Publicado: (2023) -
The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)
por: Brenner, Jacob S., et al.
Publicado: (2017) -
Zoster Sine Herpete Masquerading as Central Nervous System Vasculitis
por: Lau, Arthur, et al.
Publicado: (2020) -
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
por: Bassetti, Matteo, et al.
Publicado: (2020)